- Filed
- Apr 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Apr 11, 2025 | 20.25M sh |
| Shares Diluted | FY 2024 · Dec 31, 2023 | 20.25M sh |
| Capex | FY 2024 · Dec 31, 2023 | $746 |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | −$316.92K |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $174.88K |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $756K |
| Current Assets | FY 2024 · Dec 31, 2023 | $349.6K |
| Total Assets | FY 2024 · Dec 31, 2023 | $365.18K |
| Eps Diluted | FY 2024 · Dec 31, 2023 | −$0.02 |
| Eps Basic | FY 2024 · Dec 31, 2023 | −$0.02 |
| Sga Expense | FY 2024 · Dec 31, 2023 | $465.23K |
| Net Income | FY 2024 · Dec 31, 2023 | −$403.7K |
| Operating Income | FY 2024 · Dec 31, 2023 | −$404.64K |
| Gross Profit | FY 2024 · Dec 31, 2023 | $64.14K |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $94.33K |
| Revenue | FY 2024 · Dec 31, 2023 | $158.48K |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $17.43K |